Core competency frameworks for the education of pharmacists in Türkiye: EczÇEP-2015 and EczÇEP-2019

Abstract

Education in pharmaceutical sciences is a major concern in every nation. It has many stakeholders in different categories, who are in expectation of a satisfactory level in terms of skills, competencies, knowledge, etc. As the dynamics of pharmaceutical sciences have been changing due to the tremendous amount of pharmaceutical research, the requirement for a renewal of pharmacy education has emerged in Türkiye. In the year of 2015, this requirement was imposed by The Council of Higher Education of Türkiye (CoHE/YÖK) through the Medicine Health Sciences Education Council of Türkiye (MHSEC/TSBEK), as well as the Turkish Pharmacists’ Association (Türk Eczacılar Birliği, TPA/TEB) plus the influences of global organisations like FIP (The International Pharmaceutical Federation), WHO (World Health Organisation). Subsequently, the Deans Council of Pharmacy Faculties of Türkiye (DCPF), consisting of 32 members, decided immediately to prepare a competency framework for pharmacists in Türkiye and established a sub-committee for this purpose. The sub-committee, which consisted of 25 members as Deans and ViceDeans, has prepared a draft for the competency framework for the pharmacy education and to approve to DCPF, and then MHSEC/TSBEK. After final approval from CoHE/YÖK, the first core competency framework for pharmacists was implemented by the Pharmacy Faculties in Türkiye. After this framework, an updated version was completed in 2019 with a similar process. The second frame work (EczÇEP-2019) is more useful than the first one in terms of its applicability and practise.

Keywords

• Pharmacy education
• Core competency
• Curriculum development
• Qualifications in pharmacy

References

1. Anderson, C. & Futter, B. (2009). PharmD or needs based education: which comes first? American Journal of Pharmacy Education, 73(5): a92, 1-3. https://doi.org/ 10.5688/aj730592 google scholar
2. Batta, A., Kalra, B. S., & Khirasaria, R. (2020). Trends in FDA drug approvals over last 2 decades: An observational study. Journal of Family Medicine and Primary Care, 9(1), 105-114. https://doi.org/10.4103/jfmpc.jfmpc_578_19 google scholar
3. Bheekie, A., Van Huyssteen, M. & Coetzee, R. (2019). Exploring the Implications of a Needs-Based Pharmacy Education Framework Modelled on Population Health: Perspective from a Developing Country. Pharmacy (Basel), 7(3), e116, 1-12. https://doi.org/10.3390/pharmacy7030116 google scholar
4. DCPF (2024). Deans Council of Pharmacy Faculties of Türkiye, http://eczdekankonsey. org.tr/hakkimizda/ (last accessed on 1 March 2025). google scholar
5. ECZAKDER (2021). Association for evaluation and accreditation of pharmacy edu-cation programs, Ankara, Türkiye. https://www.eczakder.org.tr/?sDil=2 (last accessed on 1 March 2025). google scholar
6. Lessenger, J. E., & Feinberg, S. D. (2008). Abuse of prescription and over-the-counter medications. The Journal of the American Board of Family Medicine, 21(1), 45-54. https://doi.org/10.3122/jabfm.2008.01.070071 google scholar
7. Paloumpi, E., Ozieranski, P., Watson, M. C., & Jones, M. D. (2023). Professional stakeholders’ expectations for the future of community pharmacy practice in England: a qualitative study. British Medical Journal open, 13(10), e075069. https://bmjopen.bmj.com/content/bmjopen/13/10/e075069.full.pdf (last ac-cessed on 1 March 2025). google scholar
8. Pathak, G., & Bhola, S. S. (2014). Stakeholders in pharmaceutical business. ZENITH International Journal of Multidisciplinary Research, 4(3), 155-158. https://ssrn. com/abstract=2589467 google scholar

9. Sarnak, D. O., Squires, D., Kuzmak, G., & Bishop, S. (2017). Paying for prescription drugs around the world: why is the US an outlier. Issue Brief (Com-monw Fund) 2017, 1-14. https://www.commonwealthfund.org/sites/default/ files/documents/___media_files_publications_issue_brief_2017_oct_sarnak_ paying_for_rx_ib_v2.pdf (last accessed on 1 March 2025). google scholar
10. Taylor, S. M., Cairns, A., & Glass, B. D. (2021). Rural pharmacists and stakeholders’ perspectives of expanded pharmacy practice: A descriptive study. Australian Journal of Rural Health, 29(3), 341-353. https://doi.org/10.1111/ajr.12739 google scholar
11. TEİS (2021). Eczdek-3.Çekirdek Eğitim Programı Çalıştay Raporu, March 4, 2021. https://www.teis.org.tr/post/eczdek-3cekirdek-egitim-programi-calistay-raporu-20210304 (last accessed on 1 March 2025). google scholar
12. Thiers, F., Sinskey, A. & Berndt, E. (2008). Trends in the globalization of clinical trials. Natura Review Drug Discovery 7, 13-14. https://doi.org/10.1038/nrd2441 google scholar
13. Tichy, E.M. Schumock, G.T., Hoffman, J.M., Suda, K.J., Rim, M.H., Tadrous, M., Stubbings, J.-A., Cuellar, S., Clark, J.S., Wiest, M.D., Matusiak, L.M., Hunkler, R.J. & Vermeulen, L.C. (2020). National trends in prescription drug expenditures and projections for 2020. American journai of Heaith-System Pharmacy 77(15), 1213-1230. https://doi.org/10.1093/ajhp/zxaa116 google scholar
14. Wellcome Trust Consultation Response (2016). Purpose and quality of education in England inquiry: Evidence from the Wellcome Trust, 27 January 2016. https:// wellcome.org/sites/default/files/wtp060177.pdf (last accessed on 1 March 2025). google scholar
15. WHO Report (1997). The role of the pharmacist in the health care system - Prepar-ing the future pharmacist: curricular development, Report of a third WHO consultative group on the role of the pharmacist, Vancouver, Canada, 27-29 August 1997. https://iris.who.int/bitstream/10665/63817/1/WHO_PHARM_97_ 599.pdf (last accessed on 1 March 2025). google scholar
16. Wiedenmayer, K., Summers, R. S., Mackie, C. A., Gous, A. G. S., Everard, M. & Tromp, D. (2006). Developing pharmacy practice: A focus on patient care, World Health Organization Department of Medicines Policy and Standards Geneva, Switzerland. https://www.fip.org/files/fip/publications/DevelopingPharmacy Practice/DevelopingPharmacyPracticeEN.pdf (last accessed on 1 March 2025). google scholar